Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting

Completed

• Conditions: Ciprofloxacin Adverse Reaction
• Interventions: Drug: Ciprofloxacin Tablets

• Registration Number: NCT05916105
• Lead Sponsor: Damanhour University

Brief Summary

Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use.

Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.

Detailed Description

From September 2021 to February 2022, a cross-sectional, research was undertaken to evaluate ciprofloxacin usage. The investigation was carried out by community pharmacists in seven Egyptian community pharmacies.

Data Collection: data gathered from pharmacy patients' records on a data collection form that included the factors indicated. The General Symptoms Questionnaire, physical examination, and blood testing were used to identify adverse occurrences.

Study variables:

* age, gender, pregnancy/lactation

* Department/indication

* Dose, Frequency, Duration, Adverse events, Drug interactions.

Data was categorized and analyzed using appropriate software.

Study Timeline

• Study Start: 2021-09-01
• Primary Completion: 2022-02-28
• Study Completion: 2022-03-01
• Status Verified: 2023-06
• Study First Submitted: 2023-06-13
• Study First Submitted QC: 2023-06-13
• Last Update Submitted: 2023-06-13
• Study First Posted: 2023-06-23
• Last Update Posted: 2023-06-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 151

Inclusion Criteria

• All ciprofloxacin included prescription during the study period.

Exclusion Criteria

• un included ciprofloxacin prescription.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Ciprofloxacin	Ciprofloxacin Tablets	151 record of Ciprofloxacin

Primary Outcome Measures

Name	Time	Method
Indications	6 months	Appropriate Indications of ciprofloxacin (frequency )
ciprofloxacin prescription (frequency )	6 months	Number of appropriate ciprofloxacin prescription
adverse events	6 months	adverse events occured during ciprofloxacin therapy (frequency )

Trial Locations

Locations (1)

Rehab Hussein Werida; 🇪🇬 Damanhūr, Elbehairah, Egypt